Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For institutional use only, Mfg by: Aenova Holding GmBh, Miami, Fl 33186, NDC 63739-0478-10
Published March 27, 2019 · Recall initiated: January 16, 2019
Summary
FDA records drug Class II recall D-1007-2019, published March 27, 2019 and initiated January 16, 2019. Recalling firm: Rx Pak Division of McKesson Corporation; Status: Terminated; Reported quantity: 29,622 Blister Cards; Lot: Lot # 0119397, Exp 02/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Rx Pak Division of McKesson Corporation
- Distributor
- Product was distributed to 5 major distributors who may have further distributed the product throughout the United States.
- Lot
- Lot # 0119397, Exp 02/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVolumex (Iodinated I 131 Albumin) Injection USP, 25 uCi per 1 mL syringe, Rx Only, Manufactured for DaxorMarch 27, 2019
- FDATestosterone Topical Solution, 30mg/1.5mL, 110mL bottles, Rx only, Manufactured for: Lupin PharmaceuticalsMarch 27, 2019
- FDAHydrocortisone and Acetic Acid Otic Solution, USP, 10 mL per dropper bottle, Rx only, Hi-Tech Pharmacal Co,March 27, 2019
- FDAOssur, ReSolve Halo Vest, Part/ Description: 545700K/ ReSolve Halo Vest-shrt kodel; 545700L/ ReSolve HaloMarch 20, 2019
- FDAOssur OB Resolve, Sterile, Part/ Description: 505300D/ OB RESOLVE STERILE RING SML; 505400D/ OB RESOLVE RINGMarch 20, 2019
- FDAOssur Skull Pin, Sterile Ceramic Tip Pin, Part/ Description: 516CS/ Skull Pin 2-1/4in CT Sterl 1PK; 516DS/March 20, 2019
Questions about this recall
Was Docusate Sodium, 100mg softgels, packaged in 10 x 10 unit dose blister cards, For institutional use only, Mfg by: Aenova Holding GmBh, Miami, Fl 33186, NDC 63739-0478-10 recalled?
Yes. FDA published recall D-1007-2019 on March 27, 2019. Reported hazard: Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.
What should I do if I have this product?
Voluntary: Firm initiated · Letter